The reiteration of an Outperform rating and maintenance of a $140 price target by a reputable analyst like Shagun Singh from RBC Capital could positively influence investor sentiment towards Zimmer Biomet Holdings. This endorsement reaffirms the analyst's confidence in the company's future performance, potentially leading to increased investor interest and a positive short-term impact on the stock price.